β-Cyclodextrin-grafted hyaluronic acid as a supramolecular polysaccharide carrier for cell-targeted drug delivery.

[1]  Yongli Chen,et al.  Hyaluronic-acid-based β-cyclodextrin grafted copolymers as biocompatible supramolecular hosts to enhance the water solubility of tocopherol. , 2020, International journal of pharmaceutics.

[2]  S. Lecommandoux,et al.  Design of polysaccharide-b-elastin like polypeptide bioconjugates and their thermoresponsive self-assembly. , 2019, Biomacromolecules.

[3]  R. Miraftab,et al.  Feasibility and Potential of Graphene and Its Hybrids with Cellulose as Drug Carriers:A Commentary , 2019 .

[4]  Nan Song,et al.  Stimuli-Responsive Drug-Delivery Systems Based on Supramolecular Nanovalves , 2019, Matter.

[5]  M. Grinstaff,et al.  Polymer–drug conjugate therapeutics: advances, insights and prospects , 2018, Nature Reviews Drug Discovery.

[6]  S. Shakya,et al.  Biofunctionalization of β-cyclodextrin nanosponges using cholesterol. , 2018, Carbohydrate polymers.

[7]  Jian-yong Wu,et al.  Protective effects of natural and partially degraded konjac glucomannan on Bifidobacteria against antibiotic damage. , 2018, Carbohydrate polymers.

[8]  Mingyu He,et al.  Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid. , 2017, Acta biomaterialia.

[9]  Jingkun Yan,et al.  Construction and characterization of nanosized curdlan sulfate/chitosan polyelectrolyte complex toward drug release of zidovudine. , 2017, Carbohydrate polymers.

[10]  Leaf Huang,et al.  Targeted drug delivery to melanoma. , 2017, Advanced drug delivery reviews.

[11]  Zhen Gu,et al.  Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. , 2016, Nano letters.

[12]  G. Crini,et al.  Review: a history of cyclodextrins. , 2014, Chemical reviews.

[13]  Robert Langer,et al.  A Perspective on the Clinical Translation of Scaffolds for Tissue Engineering , 2014, Annals of Biomedical Engineering.

[14]  Byung-Heon Lee,et al.  Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy , 2014, Nature Communications.

[15]  Kwangmeyung Kim,et al.  Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Chengzhong Yu,et al.  Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. , 2013, Nanoscale.

[17]  Zhengyu Jin,et al.  A thermogravimetric analysis (TGA) method developed for estimating the stoichiometric ratio of solid-state α-cyclodextrin-based inclusion complexes , 2012 .

[18]  G. Lazzara,et al.  Microwave-assisted synthesis of novel cyclodextrin–cucurbituril complexes , 2011 .

[19]  Kwangmeyung Kim,et al.  Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. , 2011, ACS nano.

[20]  Sei Kwang Hahn,et al.  Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. , 2011, ACS nano.

[21]  Jiawen Zhou,et al.  Cyclodextrin functionalized polymers as drug delivery systems , 2010 .

[22]  William B. Liechty,et al.  Polymers for drug delivery systems. , 2010, Annual review of chemical and biomolecular engineering.

[23]  D. Dudek,et al.  Designed biomaterials to mimic the mechanical properties of muscles , 2010, Nature.

[24]  Gorka Orive,et al.  Biomaterials for promoting brain protection, repair and regeneration , 2009, Nature Reviews Neuroscience.

[25]  Tae Gwan Park,et al.  Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. , 2009, Macromolecular bioscience.

[26]  R. Auzély-Velty,et al.  Controlled synthesis and inclusion ability of a hyaluronic acid derivative bearing beta-cyclodextrin molecules. , 2006, Biomacromolecules.

[27]  Mark E. Davis,et al.  Cyclodextrin-based pharmaceutics: past, present and future , 2004, Nature Reviews Drug Discovery.

[28]  J. Sleeman,et al.  Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid , 2001, Oncogene.

[29]  R. Gillies,et al.  pH and drug resistance in tumors. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[30]  L. Šoltés.  Cyclodextrin derivative of hyaluronan , 1999 .

[31]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[32]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[33]  R. Savani,et al.  Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation , 1995, Cell.

[34]  W. Knudson,et al.  Hyaluronan‐binding proteins in development, tissue homeostasis, and disease , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  W. Knudson,et al.  Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. , 1993, Journal of cell science.

[36]  Robert Langer,et al.  Supramolecular biomaterials. , 2016, Nature materials.

[37]  J. Sleeman,et al.  How tumor cells make use of CD44. , 1998, Cell adhesion and communication.

[38]  J. Vacanti,et al.  Tissue engineering. , 1993, Science.

[39]  T. Laurent.  The biology of hyaluronan. Introduction. , 1989, Ciba Foundation symposium.

[40]  W. G. McMillan,et al.  The assumptions of the B.E.T. theory. , 1951, The Journal of physical and colloid chemistry.